Every batch, independently verified.
Each batch is analyzed by an ISO/IEC 17025 accredited third-party laboratory before it ships. This is the released report for the current batch, exactly as the lab signed it.
FOX-04 DRI™
Cellular Renewal & Senolytic Research
FOX-04 DRI™ is an investigational peptide studied for its senolytic potential—the selective targeting of senescent (“zombie”) cells that accumulate with age and cellular stress. Research suggests that reducing the burden of senescent cells may support healthier tissue function, recovery, and longevity by promoting a more youthful cellular environment.
Key Research Areas
- Supports the selective clearance of senescent cells
- Promotes healthy cellular renewal and tissue function
- Studied for longevity and healthy aging
- May help support recovery and regenerative processes
- Investigated for overall cellular health and resilience
For Research Use Only. Not for human consumption.
Compound Information
What Is FOXO4-DRI?
A D-retro-inverso peptide engineered to disrupt the FOXO4-p53 protein interaction inside senescent cells, studied as a senolytic research compound that can selectively trigger apoptosis in senescent cells.
Stability Information
Keep the lyophilized powder frozen and shielded from light until use. Once reconstituted, store refrigerated and use within a few weeks, or freeze small aliquots for longer storage.
